Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

Improve your knowledge on bispecific antibodies in hematologic malignancies, including essential information on their mechanisms of action, clinical considerations, and safety profiles. This on-demand webcast with accompanying slides includes faculty insights on bispecific antibodies for multiple myeloma and B-cell lymphoma, highlighting current evidence, treatment pathways, and strategies for effective patient management.

Share

Program Content

Activities

Bispecific Antibodies in Heme Nursing
Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2024

Expires: April 13, 2025

Activities

Bispecific Antibodies Across Hematologic Malignancies
Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 26, 2024

Expires: April 23, 2025

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC